The abstract on the development and early clinical successes of EXCOR® Revive was awarded the ASAIO Oral Abstract Award in the pediatric category. Co-author of the abstract, Ares K. Menon, MD, will present the paper on June 9th, 2022, 3:55 p.m. - 4:05 p.m. CST. Prizes will be awarded to the top abstracts in each category and are valued at 1,000 USD. The prize money has been donated and will benefit ASAIO's promotion of young scientists.
Read the abstract: Zimpfer et al.: Development and first clinical experience of a novel cannula for sub-pulmonary mechanical circulatory support in patients with failing Fontan circulation
Registration and further information about the ASAIO 67th Annual Conference: ASAIO - 67th Annual Conference
The access to some or all shown products may be restricted by country-specific regulatory approvals. The use of EXCOR® VAD for adults, RVAD-support, EXCOR® Venous Cannula, EXCOR® Arterial Cannula for Graft as well as Excor mobile is not FDA approved. EXCOR® Active is an investigational device approved for use in a clinical study under IDE# G200252 approved by the FDA.